WeVote

Bill

Bill

HB 95

Relating to a restriction on the sale or distribution of an abortion-inducing drug through an Internet website.

89th Legislature, 1st Called Session (2025) Introduced by Andy Hopper and 1 co-sponsor

Texas bill would ban online sales of abortion-inducing drugs, restricting remote access to FDA-approved medication abortion and potentially limiting healthcare access in underserved areas.

Filed
0
WeVote Research Nonpartisan
Bill Summary · HB 95

Legislative bill overview

HB 95 would restrict the sale or distribution of medication abortion drugs (mifepristone) through internet websites in Texas. The bill appears designed to prevent remote access to abortion-inducing medications, requiring any such transactions to occur through in-person channels if permitted at all under existing law.

Why is this important

Medication abortion currently accounts for over half of all U.S. abortions and is FDA-approved for use up to 10 weeks of pregnancy. Internet-based access removes geographic and logistical barriers for patients, particularly in rural areas. This bill directly impacts access to a federally-approved medical service and reflects ongoing state-level restrictions following the 2022 Dobbs decision.

Potential points of contention

  • Federal preemption questions: The FDA has approved mifepristone for mail distribution; state restrictions may face legal challenges on constitutional grounds and potential conflict with federal regulatory authority
  • Enforcement mechanisms: The bill's specifics on how internet sales would be identified and prosecuted, and whether it applies to telehealth providers or only direct-to-consumer websites, remain unclear from the filing
  • Healthcare access equity: Restrictions disproportionately affect rural residents, lower-income individuals, and those with transportation limitations who rely on remote pharmaceutical access

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.